Integra outlines $1.634B-$1.654B 2026 revenue outlook as disruption extends
FROM THE WIRE · SEEKINGALPHA.COM
Earnings Call Insights: Integra LifeSciences (IART) Q3 2026 MANAGEMENT VIEW * "For the third quarter, we delivered revenue of $411 million, which was at the low end of our guidance range" (CEO, President & Chairman Stuart Essig). "We delivered adjusted earnings per share of…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishA cut of about $30M to the revenue guidance midpoint weighs on expectations for the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Q3 revenue was $411 million, at the low end of the guidance range.
- 02The midpoint of full-year revenue guidance was cut by about $30 million.
- 03The Cincinnati disruption is expected to reduce fourth-quarter revenue by $15 million to $20 million.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets